SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Treating symptomatic uterine fibroids with myomectomy: current practice and views of UK consultants

Sirkeci, RF; Belli, AM; Manyonda, IT (2017) Treating symptomatic uterine fibroids with myomectomy: current practice and views of UK consultants. GYNECOLOGICAL SURGERY, 14. p. 11. ISSN 1613-2076 https://doi.org/10.1186/s10397-017-1014-4
SGUL Authors: Belli, Anna Maria

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (512kB) | Preview

Abstract

Background: The demand for uterus-sparing treatments is increasing as more women postpone childbirth to their 30–40s, when fibroids are more symptomatic. With an increasing choice of treatment options and changing care-provider profiles, now is an opportune time to survey current practices and opinions. Using a 25-stem questionnaire, a web-based survey was used to capture the practices and opinions of UK consultant gynecologists on the treatment of symptomatic fibroids, including the types of procedure most frequently used, methods used to reduce blood loss, and awareness and acceptability of treatment options, and to assess the impact of gender and experience of the treating gynecologist. Results: The response rate was 22%. Laparascopic myomectomy is used least frequently, with 80% of the respondents using GnRHa preoperatively to minimize blood loss and correct anemia, while vasopressin is most frequently used to reduce intraoperative blood loss. Female consultants operate significantly less frequently than males. Those with more than 10 years consultant experience are more likely to perform an open myomectomy compared to those with less than 10 years experience. Conclusions: Compared to a similar survey performed 10 years ago, surgical methods remain to be the most common treatments, but use of less invasive treatments such as UAE has increased. Consultants’ attitudes appear to be responding to the patient demand for less radical treatments. However, it is yet to be seen if the changing consultant demographics will keep up with this demand. The low response rate warrants cautious interpretation of the results, but they provide an interesting snapshot of current views and practices.

Item Type: Article
Additional Information: © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Fibroids, Myomectomy, UAE, GnRHa, Vasopressin, Consultant practices, Obstetrics & Reproductive Medicine, 1114 Paediatrics And Reproductive Medicine
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Vascular (INCCVA)
Journal or Publication Title: GYNECOLOGICAL SURGERY
ISSN: 1613-2076
Dates:
DateEvent
6 July 2017Published
12 June 2017Accepted
Publisher License: Creative Commons: Attribution 4.0
Web of Science ID: WOS:000405014400001
URI: https://openaccess.sgul.ac.uk/id/eprint/109103
Publisher's version: https://doi.org/10.1186/s10397-017-1014-4

Actions (login required)

Edit Item Edit Item